Buscar en
Annals of Hepatology
Toda la web
Inicio Annals of Hepatology
Journal Information
Vol. 29. Issue 3.
(May - June 2024)
Editorial board
Ann Hepatol. 2024;29:101504
Full text access
The 2023 meeting of the Latin American Association for the Study of the Liver: A summary and looking ahead
Francisco Javier Valentin-Cortez, Norberto Chávez-Tapia
Ann Hepatol. 2024;29:101476
Full text access
Liver rupture in patients with amyloidosis: Clinical features and treatment
Xiangyu Du, Liangzhi Wen, Bin Wang, Dongfeng Chen, Wei Wang
Ann Hepatol. 2024;29:101500
Full text access
Concise reviews
Pathophysiology of ascites: The importance of the intestine. A surgical contribution to the understanding of a medical problem
Gabriel E. Gondolesi, Carolina Rumbo, Leonardo Montes, Lucia Novellis, Diego Ramisch, Ariel Riquelme Henríquez, Mariana Ortega, Federico Viano, ... Héctor Solar
Ann Hepatol. 2024;29:101498
Full text access
Original articles
Gradual dosing of ursodeoxycholic acid in mothers with intrahepatic cholestasis of pregnancy may improve composite neonatal outcome
Amir Hamud, Matan J. Cohen, Drorith Hochner-Celnikier, Benjamin Bar-Oz, Zvi Ackerman
Ann Hepatol. 2024;29:101490
Full text access
Lean non-alcoholic fatty liver disease and the risk of all-cause mortality: An updated meta-analysis
Wasit Wongtrakul, Natthinee Charatcharoenwitthaya, Phunchai Charatcharoenwitthaya
Ann Hepatol. 2024;29:101288
Full text access
Outcomes and factors associated with relapse of vaccine-induced liver injury after SARS CoV-2 immunization: A nationwide study
Ana Barreira-Díaz, Mar Riveiro-Barciela, Eva María Fernández-Bonilla, Vanesa Bernal, Agustín Castiella, Marta Casado-Martín, Carolina Delgado, María-Carlota Londoño, ... Magdalena Salcedo
Ann Hepatol. 2024;29:101489
Full text access
Neurofilament light chain but not glial fibrillary acidic protein is a potential biomarker of overt hepatic encephalopathy in patients with cirrhosis
Koos de Wit, Diederick J. van Doorn, Bregje Mol, Lonneke A. van Vught, Frederik Nevens, Ulrich Beuers, Cyriel Y. Ponsioen, Charlotte E. Teunissen, R. Bart Takkenberg
Ann Hepatol. 2024;29:101496
Full text access
Influence of socioeconomic factors on liver transplant survival outcomes in patients with autoimmune liver disease in the United States
Leandro Sierra, Ana Marenco-Flores, Romelia Barba, Daniela Goyes, Bryan Ferrigno, Wilfor Diaz, Esli Medina-Morales, Behnam Saberi, ... Alan Bonder
Ann Hepatol. 2024;29:101283
Full text access
Societal costs and survival of patients with biopsy-verified non-alcoholic steatohepatitis: Danish nationwide register-based study
Jan Håkon Rudolfsen, Lise Lotte Gluud, Henning Grønbæk, Majken K. Jensen, Mogens Vyberg, Jens Olsen, Peter Bo Poulsen, Nanna Hovelsø, ... Peter Jepsen
Ann Hepatol. 2024;29:101285
Full text access
Development and validation of a noninvasive prediction model for significant hepatic liver fibrosis in Chinese patients with autoimmune hepatitis
Hanzhu Chen, Wenya Ren, Xingdi Yang, Piao Hu, Shouhao Wang, Chengan Xu, Fei Lv, Yue Zhao, ... Hongying Pan
Ann Hepatol. 2024;29:101287
Full text access
Dietary macro and micronutrients associated with MASLD: Analysis of a national US cohort database
Mary Nemer, Fauzia Osman, Adnan Said
Ann Hepatol. 2024;29:101491
Full text access
Letters to the editor
Prevalence and mortality prognosis of steatotic liver disease phenotypes
Zhiyu Sun, Chi Zhou, Yiwen Zhang, Pengfei Li, Junjie Guo, Zhexun Lian, Hongwei Ji
Ann Hepatol. 2024;29:101487
Full text access
MASLD identifies patients with significant hepatic fibrosis and steatosis in fatty liver population
You Deng, Wenya Chen, Wen Xie
Ann Hepatol. 2024;29:101488
Full text access
Hot topics in hepatology: a multinational perspective
The burden of liver disease in Latin America
Luis Antonio Díaz, Marcela Villota-Rivas, Francisco Barrera, Jeffrey V. Lazarus, Marco Arrese
Ann Hepatol. 2024;29:101175
Full text access
From evidence to clinical practice: Bridging the gap of new liver cancer therapies in Latin America.
Federico Piñero, Ezequiel Mauro, Paola Casciato, Alejandro Forner
Ann Hepatol. 2024;29:101185
Full text access
Occult liver disease: A multinational perspective
Paulina Vidal-Cevallos, Nayelli Flores-García, Norberto C. Chávez-Tapia, Naga P. Chalasani
Ann Hepatol. 2024;29:101480
Full text access
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos